| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $177M | — | — | — | — |
| Op. Income | $55M | — | — | — | — |
| Gross Margin | 45.7% | — | — | — | — |
| Net Margin | 10.7% | — | — | — | — |
| EPS (Diluted) | $0.18 | — | — | — | — |
| Free Cash Flow | $24M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $177M |
| Cost of Revenue | $96M |
| GROSS PROFIT | $81M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $26M |
| SG&A Expenses | $26M |
| Other Expenses | $0 |
| Operating Expenses | $26M |
| Cost & Expenses | $122M |
| OPERATING INCOME | $55M |
| Interest Income | $2M |
| Interest Expense | $6M |
| Other Income/Expenses | $9M |
| INCOME BEFORE TAX | $64M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $58M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $19M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $19M |
| D&A | $1M |
| EBIT | $70M |
| EBITDA | $71M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $177M |
| Cost of Revenue | $96M |
| GROSS PROFIT | $81M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $26M |
| SG&A Expenses | $26M |
| Other Expenses | $0 |
| Operating Expenses | $26M |
| Cost & Expenses | $122M |
| OPERATING INCOME | $55M |
| Interest Income | $2M |
| Interest Expense | $6M |
| Other Income/Expenses | $9M |
| INCOME BEFORE TAX | $64M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $58M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $19M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $19M |
| D&A | $1M |
| EBIT | $70M |
| EBITDA | $71M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $19M |
| Depreciation & Amortization | $1M |
| Stock-Based Compensation | $13M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $39M |
| Change in Working Capital | -$43M |
| OPERATING CASH FLOW | $28M |
| Capital Expenditure | -$5M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$52M |
| Sales/Maturities of Investments | $5M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$52M |
| Net Debt Issuance | -$1M |
| Common Stock Repurchased | -$31M |
| Common Dividends Paid | -$7M |
| Other Financing Activities | -$44M |
| NET CASH FROM FINANCING | $83M |
| FREE CASH FLOW | $24M |
| Net Change in Cash | $59M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $242M |
| Short-Term Investments | $0 |
| Net Receivables | $112M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $355M |
| PP&E (Net) | $70M |
| Goodwill | $0 |
| Intangible Assets | $29M |
| Long-Term Investments | $275M |
| Tax Assets | $0 |
| Other Non-Current Assets | $85M |
| TOTAL NON-CURRENT ASSETS | $459M |
| TOTAL ASSETS | $814M |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$55M |
| TOTAL CURRENT LIABILITIES | $151M |
| Long-Term Debt | $428M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $55M |
| TOTAL NON-CURRENT LIABILITIES | $535M |
| TOTAL LIABILITIES | $686M |
| Common Stock | $20.0K |
| Additional Paid-In Capital | $44M |
| Retained Earnings | -$16M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$770.0K |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $27M |
| Minority Interest | $100M |
| TOTAL EQUITY | $127M |
| TOTAL LIABILITIES & EQUITY | $814M |
| Total Debt | $480M |
| Net Debt | $238M |
